Table 1.
Patients (n = 62) | |
---|---|
Gender | |
Female | 42% (n = 26) |
Male | 58% (n = 36) |
Age (y) | |
Range | 49‐86 |
Median | 66 |
Performance status | |
ECOG 0 | 53% (n = 33) |
ECOG 1 | 47% (n = 29) |
Smoking history | |
Yes | 97% (n = 60) |
Smoking during radiation | |
Yes | 10% (n = 6) |
Diabetes mellitus II | |
Yes | 26% (n = 16) |
Pulmonary disease | |
COPD | 26% (n = 16) |
Asthma | 5% (n = 3) |
Stage | |
IIIA | 27% (n = 17) |
IIIB | 53% (n = 33) |
IIIC | 20% (n = 16) |
PD‐L1 expression | |
Unavailable | 17% (n = 11) |
≥1% | 53% (n = 33) |
≥50% | 29% (n = 18) |
Patient characteristics are from time of initiation of radiation therapy.